For research use only — not for human or veterinary use.
Analytical Verification (COA)
Each batch of CJC-1295 + Ipamorelin supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.
Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.
Batch: GF-CJCIPA10/10-B242
Key analytical results include:
Ipamorelin Assay Content: 10.26 mg CJC-1295 (MOD GRF 1-29) Assay Content: 11.19 mg Ipamorelin Identification – Retention Time: 0.994 CJC-1295 Identification – Retention Time: 0.991 Ipamorelin Identification – Spectrum: 996 CJC-1295 Identification – Spectrum: 993 Purity: high purity confirmed for both peptides Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected
Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.
These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.
Product Overview
CJC-1295 + Ipamorelin is a dual peptide research blend studied in controlled laboratory environments focused on peptide-mediated signalling pathways and regulatory systems.
The combination is commonly investigated in biochemical research for its interaction with peptide signalling mechanisms and molecular regulatory processes.
This preparation contains a total of 20 mg of high purity lyophilized peptides supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compounds for controlled in vitro experimentation.
Due to the defined dual-peptide structure and stable analytical profile, this blend is frequently referenced in experimental peptide research models.
Compound Overview
CJC-1295 (MOD GRF 1-29) and Ipamorelin are synthetic peptides studied in biochemical research for their interaction with signalling pathways and regulatory systems.
Within experimental models, these compounds are commonly investigated for their interaction with peptide-mediated signalling networks and molecular mechanisms.
Because of their combined molecular profile, this blend is frequently used in laboratory studies examining peptide signalling and regulatory processes.
Historical Background and Scientific Context
Scientific interest in synthetic peptides has expanded significantly with advances in molecular biology and biochemical research.
Peptides such as CJC-1295 and Ipamorelin have been developed to explore signalling pathways and receptor interactions in controlled laboratory environments.
This has enabled deeper investigation into molecular mechanisms and peptide-mediated biological processes.
Mechanistic Focus in Research
Within experimental laboratory settings, this peptide blend is commonly studied in relation to peptide-mediated signalling pathways.
Research investigations commonly explore the compounds in experimental models examining:
Peptide signalling pathways Regulatory network interactions Peptide interaction dynamics Intracellular signalling mechanisms Comparative peptide research Molecular signalling pathway analysis Receptor interaction modelling
These experimental models allow scientists to investigate molecular mechanisms involved in peptide-mediated signalling processes.
Research Applications
In controlled research environments, this peptide blend may be utilised in experimental models designed to explore peptide signalling systems and molecular interactions.
Examples of research applications include:
Peptide signalling pathway investigation Receptor interaction research Intracellular signalling modelling Comparative peptide studies Molecular pathway analysis Controlled in vitro research Laboratory signalling studies
Grail Formula Quality
Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.
Each batch undergoes independent analytical testing to verify:
Compound identity Assay accuracy Purity confirmation Microbial safety Endotoxin levels Heavy metal screening Full batch traceability
All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.
Research Use Limitation
Used solely for in vitro experiments Not permitted for clinical trials involving humans Not permitted for human or veterinary administration Not permitted for investigational human use